p53 Gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix

American Journal of Pathology

Volumn 143, Issue 5, 1993, Pages 1398-1405

  Kessis, Theodore D ^a   Slebos, Robbert J ^b   Han, Sung M ^b   Shah, Keerti ^a   Bosch, Xavier F ^c   Muñoz, Nubia ^c   Hedrick, Lora ^b   Cho, Kathleen R ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; SINGLE STRANDED DNA; VIRUS DNA;

ADENOCARCINOMA; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; WART VIRUS;

ADENOCARCINOMA; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENES, P53; HUMANS; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

EID: 0027769911     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. zur Hausen H: Papillomaviruses as carcinomaviruses. Adv Virol Oncol 1989, 8:1-26
2. Riou G, Favre M, Jeannel D, Bourhis J, LeDoussal V. Orth G Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 1990, 335:1171-1174
3. Schwarz E, Freese UK, Gissmann L et al: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985, 314:111-114
4. Smotkin D, Wettstein F: Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer derived cell line and identification of E7 protein. Proc Natl Acad Sci USA 1986, 83:4680-4684
5. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM: Structural and transcriptional anal of human papillomavirus type 16 sequences in cecal carcinoma cell lines. J Virol 1987, 61:962-971
6. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DB Schiller JT: HPV16 E6 and E7 proteins cooperat to immortalize human foreskin keratinocytes. EMBO J 1989, 8:3905-3910
7. Münger K, Phelps W, Bubb V, Howley P, Schlegel R The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989, 63:4417-4421
8. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990, 248:76-79
9. Crook T, Tidy JA, Vousden KH: Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 1991, 67:547-556
10. Scheffner M, Werness BA, Huibregtse JM, Levine AJ. Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136
11. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53 associated protein in human sarcomas. Nature 1992, 358:80-83
12. Ladanyim M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH: MDM2 Gene amplification in metastatic osteosarcoma. Cancer Res 1993, 53:16-18
13. Scheffner M, Münger K, Byrne JC, Howley PM: State of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991, 88:5523-5527
14. Crook T, Wrede D, Vousden KH: p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 1991, 6:873-875
15. Muñoz N, Bosch FX, Desanjose S. et al: The casual link between human papillomavirus and invasive cervical cancer - a population-based case-control study in Columbia and Spain. Int J Cancer 1992, 52:743749
16. Bosch FX, Muñoz N, Desanjose S, et al: Risk factors for cervical cancer in Columbia and Spain. Int J Cancer 1992, 52:750-758
17. Fearon E, Hamilton S, Vogelstein B: Clonal analysis of human colorectal tumors. Science 1987, 238:193-197
18. Manos M, Ting Y, Wright A, Broker T, Wolinsky S: The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses Molecular Diagnostics of Human Cancer. Cancer Cells. Cold Spring Harbor, NY, Cold Spring Laboratory, 1989. pp 209-214
19. Southern E: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975, 98:503-506
20. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983, 132:6-13
21. Casanova J, Pannetier C, Jaulin C, Kourilsky P: Optimal conditions for direct sequencing double stranded PCR products. Nucleic Acids Res 1990, 18:4028
22. Shibata D, Arnheim N, Martin W: Detection of human papillomavirus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med 1988, 167-225-230
23. Nigro JM, Baker SJ, Preisinger AC et al: Mutations in the p53 gene occur in diverse human tumour types Nature 1989, 342:705-708
24. Rondoleon S, Vissing H, Magenis R, Kellogg J. Litt M: A hypervariable RFLP on chromosome 17p13 is defined by an arbitrary single copy probe p144-D6 [HGM9 No. D17S34]. Nucleic Acids Res 1987, 15:10605
25. Nakamura Y, Ballard L, Leppert M et al: Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30]. Nucleic Acids Res 1988, 16:5707
26. Nakamura Y, Bragg T, Ballard L et al. Isolation and mapping of a polymorphic DNA sequence (pYNH37.3) on chromosome 17p [D17S28], Nucleic Acids Res 1988, 16:782
27. Hollstein M, Sidransky D, Vogelstein B, Harris C: p53 mutations in human cancers. Science 1991, 253:49-53
28. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977, 74:5463-5467
29. Baker S, Fearon E, Nigro J et al: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989, 244:217-221
30. Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989, 5:874-879
31. Carbone D, Chiba I, Mitsudomi T: Polymorphism at codon 213 within the p53 gene. Oncogene 1991, 6:1691-1692
32. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991, 51:6304-6311
33. Kuerbitz S, Plunkett B, Walsh W, Kastan M: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992, 89:7491-7495
34. Kessis T, Slebos R, Nelson W et al: Human papillomavirus 16 E6 disrupts the p53 mediated cellular response to DNA damage. Proc Natl Acad Sci USA 1993, 90:3988-3992
35. Fearon E, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
36. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH: Clonal p53 mutation in primary cervical cancer-association with human-papillomavirus-negative tumours. Lancet 1992, 339:1070-1073
37. Kaelbling M, Burk RD, Atkin NB, Johnson AB, Klinger HP: Loss of heterozygosity on chromosome-17p and mutant p53 in HPV-negative cervical carcinomas. Lancet 1992, 340:140-142
38. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T: Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 1992, 52:5323-5328
39. Kastan M, Zhan Q, El-Diery W et al: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992, 71:587-598